Well, it took me long enough to comment on this excellent serial report from @StevenBrill on @HuffingtonPost about drug company tactics. J&J/Janssen held back data about serious problems their drug caused while continuing to tout their “putting patients first” credo. Hmmm, does that mean “first to harm?” Thanks to https://chaoticpharmacology.com/ and @pharmagossip for kicking me in gear.
Disclosure: I started the series, but didn’t finish – too incredulous at the hubris and twisted perspective of the company. I will now.
Unfortunately, they aren’t the only company exhibiting this pattern. It’s also not the only example of their dubious practices. NASDAQ also wrote this article about another J&J product: “Johnson & Johnson Settling Cases Tied to Device That Spread Uterine Cancer.”
Ever take a bunch of facts and turn them into something readable? For real people? From many dry scientific journals? When sources disagree? Vehemently? That is exactly what UCSF researchers Thea Tlsty, PhD, Philippe Gascard, PhD, and I did. Here is what we learned in order to help make sense out of a major worry for women. … Continue reading 6 Ways to Turn Data into a Good Read
This was originally posted on December 9, 2014 for nFocus Solutions, which provides great data solutions for non-profits, government agencies, and communities. Check them out (after reading this post, of course)! Do you know what funders want most? They want tangible results they can see and understand. They also want to feel like they are part of … Continue reading 7 Ways to Keep Your Funders Excited
We will all be patients someday. Respect our contributions. Include us in decisions. Set real expectations. We are family. Forever. XO All content © 2016 by Deborah Collyar unless otherwise specified. All rights reserved. Permission is granted to use short quotes provided a link back to this page and proper attribution is given to me as … Continue reading We Are the Same